Anne Siegler1, Zina Huxley-Reicher2, Lara Maldjian3, Robyn Jordan4, Chloe Oliver5, Andrea Jakubowski6, Hillary V Kunins7. 1. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: asiegler@nychhc.org. 2. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: zhuxleyreicher@health.nyc.gov. 3. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: lmaldjian1@health.nyc.gov. 4. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: rbnjordan@gmail.com. 5. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: cso2108@gmail.com. 6. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: ajakubow09@gmail.com. 7. New York City Department of Health and Mental Hygiene, 42-09 28th Street, 19th Floor, Long Island City, NY 11101, United States. Electronic address: hkunins1@health.nyc.gov.
Abstract
BACKGROUND: Providing naloxone to laypersons who are likely to witness an opioid overdose is now a widespread public health response to the national opioid overdose epidemic. Estimating the proportion of individuals who use naloxone can define its potential impact to reduce overdose deaths at a population level. We determined the proportion of study participants who used naloxone within 12 months following training and factors associated with witnessing overdose and naloxone use. METHODS: We conducted a prospective, observational study of individuals completing overdose prevention training (OPT) between June and September 2013. Participants were recruited from New York City's six largest overdose prevention programs, all operated by syringe exchange programs. Questionnaires were administered at four time points over 12 months. Main outcomes were witnessing or experiencing overdose, and naloxone administration. RESULTS: Of 675 individuals completing OPT, 429 (64%) were approached and 351 (52%) were enrolled. Overall, 299 (85%) study participants completed at least one follow-up survey; 128 (36%) witnessed at least one overdose. Of 312 witnessed opioid overdoses, naloxone was administered in 241 events (77%); 188 (60%) by the OPT study participant. Eighty-six (25%) study participants administered naloxone at least once. Over one third of study participants (30, 35%) used naloxone 6 or more months after training. CONCLUSIONS: Witnessing an overdose and naloxone use was common among this study cohort of OPT trainees. Training individuals at high risk for witnessing overdoses may reduce opioid overdose mortality at a population level if sufficient numbers of potential responders are equipped with naloxone.
BACKGROUND: Providing naloxone to laypersons who are likely to witness an opioid overdose is now a widespread public health response to the national opioid overdose epidemic. Estimating the proportion of individuals who use naloxone can define its potential impact to reduce overdose deaths at a population level. We determined the proportion of study participants who used naloxone within 12 months following training and factors associated with witnessing overdose and naloxone use. METHODS: We conducted a prospective, observational study of individuals completing overdose prevention training (OPT) between June and September 2013. Participants were recruited from New York City's six largest overdose prevention programs, all operated by syringe exchange programs. Questionnaires were administered at four time points over 12 months. Main outcomes were witnessing or experiencing overdose, and naloxone administration. RESULTS: Of 675 individuals completing OPT, 429 (64%) were approached and 351 (52%) were enrolled. Overall, 299 (85%) study participants completed at least one follow-up survey; 128 (36%) witnessed at least one overdose. Of 312 witnessed opioid overdoses, naloxone was administered in 241 events (77%); 188 (60%) by the OPT study participant. Eighty-six (25%) study participants administered naloxone at least once. Over one third of study participants (30, 35%) used naloxone 6 or more months after training. CONCLUSIONS: Witnessing an overdose and naloxone use was common among this study cohort of OPT trainees. Training individuals at high risk for witnessing overdoses may reduce opioid overdose mortality at a population level if sufficient numbers of potential responders are equipped with naloxone.
Authors: Andrea Jakubowski; Alexander Pappas; Lee Isaacsohn; Felipe Castillo; Mariya Masyukova; Richard Silvera; Louisa Holaday; Evan Rausch; Sameen Farooq; Keith T Veltri; Chinazo O Cunningham; Marcus A Bachhuber Journal: Subst Abus Date: 2018-11-26 Impact factor: 3.716
Authors: Daniel C O'Brien; Daniel Dabbs; Kathryn Dong; Paul J Veugelers; Elaine Hyshka Journal: BMC Health Serv Res Date: 2019-09-05 Impact factor: 2.655